Glucosamine hcl and Guaifenesin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glucosamine hcl and Guaifenesin. Common interactions include dermatitis allergic among females and aphasia among males.

The phase IV clinical study analyzes what interactions people who take Glucosamine hcl and Guaifenesin have. It is created by eHealthMe based on reports of 16 people who take Glucosamine hcl and Guaifenesin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

16 people who take Glucosamine hcl and Guaifenesin together, and have interactions are studied.


What is Glucosamine hcl?

Glucosamine hcl has active ingredients of glucosamine hydrochloride. eHealthMe is studying from 300 Glucosamine hcl users for its effectiveness, alternative drugs and more.

What is Guaifenesin?

Guaifenesin has active ingredients of guaifenesin. It is often used in cough. eHealthMe is studying from 10,667 Guaifenesin users for its effectiveness, alternative drugs and more.

Number of Glucosamine hcl and Guaifenesin reports submitted per year:

Glucosamine hcl and Guaifenesin drug interactions.

Common Glucosamine Hcl and Guaifenesin drug interactions by gender *:

female:

  1. Dermatitis allergic
  2. Scoliosis
  3. Temporomandibular joint syndrome
  4. Urinary tract infection
  5. Brain neoplasm
  6. Brain stem syndrome
  7. Abdominal discomfort
  8. Arthritis
  9. Cataract
  10. Tendon rupture

male:

  1. Aphasia

Common Glucosamine Hcl and Guaifenesin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Aphasia

60+:

  1. Dermatitis allergic
  2. Fall
  3. Scleroderma
  4. Scoliosis
  5. Temporomandibular joint syndrome
  6. Urinary tract infection
  7. Abdominal discomfort
  8. Arthritis
  9. Cataract
  10. Tendon rupture

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 87.50%
  2. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 1 person, 6.25%
  3. Nausea (feeling of having an urge to vomit): 1 person, 6.25%
  4. Lung Cancer - Non-Small Cell (lung cancer): 1 person, 6.25%
  5. Itching: 1 person, 6.25%
  6. High Blood Pressure: 1 person, 6.25%
  7. Chronic Fatigue Syndrome (disorder that causes extreme fatigue): 1 person, 6.25%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Glucosamine hcl and Guaifenesin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Glucosamine hcl and Guaifenesin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Guaifenesin side effects:

Browse all side effects of Guaifenesin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Guaifenesin interactions:

Browse all interactions between Guaifenesin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glucosamine hydrochloride and guaifenesin (the active ingredients of Glucosamine hcl and Guaifenesin, respectively), and Glucosamine hcl and Guaifenesin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glucosamine hcl and Guaifenesin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: